Drug Trial Radar · NCT06538662
An Investigation of FID 123320 for the Reduction of Ocular Redness in Pediatric and Adult Populations
Last checked: Nov 19, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
284
Actual
Start
Oct 7, 2024
Primary completion
Jan 27, 2025
Study completion Apr 3, 2025
Sponsor
- Lead sponsor
- Alcon ResearchIndustry
- Sponsor type
- Industry
- First posted
- Aug 6, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 5 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the safety and efficacy of FID 123320 Ophthalmic Solution (Apraclonidine HCl 0.125%) compared to Vehicle for relieving redness of the eye due to minor eye irritations in pediatric and adult populations.
Conditions
- Ocular Redness
- Eye Irritation
Interventions
Apraclonidine Hydrochloride Ophthalmic SolutionDrug
Investigational ophthalmic solution applied topically to the eye with a dropper bottle
VehicleDrug
Vehicle (inactive ingredients) applied topically to the eye with a dropper bottle
Primary outcomes
What the sponsor says the trial is designed to measure.
- Least Squares Mean Change From Baseline in Investigator-Assessed Ocular Redness at 15 Minutes Post-Instillation on Day 1 - Adult CohortTime frame: Baseline (Day 1 pre-instillation); Minute 15 (Day 1 post-instillation)
- Least Squares Mean Change From Baseline in Investigator-Assessed Ocular Redness at 10 Hours (600 Minutes) Post-Instillation on Day 1 - Adult CohortTime frame: Baseline (Day 1 pre-instillation); Hour 10 (600 minutes) (Day 1 post-instillation)
- Least Squares Mean Change From Baseline in Investigator-Assessed Ocular Redness at 1 Hour (60 Minutes) Post-Instillation on Day 1 - Pediatric Cohort (12-17 Years)Time frame: Baseline (Day 1 pre-instillation); Hour 1 (60 minutes) (Day 1 post-instillation)
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
Eye Research Foundation
Newport Beach, California
Vision Institute
Colorado Springs, Colorado
Butchertown Clinical Trials
Louisville, Kentucky
Andover Eye Associates
Andover, Massachusetts
NC Eye Associates, OD, PLLC
Apex, North Carolina
CORE, Inc.
Shelby, North Carolina
Total Eye Care PA
Memphis, Tennessee
Advancing Vision Research, LLC
Smyrna, Tennessee
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.